- The association of non-alcoholic fatty liver disease and advanced hepatic fibrosis with cardiovascular mortality in Taiwanese adults: a longitudinal cohort studyWei, X.; Yu, T.; Bo, Y.; Ho, K.; Lao, X.Annual Meeting of the European-Society-of-Cardiology (ESC), Amsterdam, NETHERLANDS, 2023-08-25 To 2023-08-28.
- Association of non-alcoholic fatty liver disease and all-cause mortality in hospitalized cardiovascular disease patientsSurasak, Saokaew; Sukrit, Kanchanasurakit; Kanitta, Thawichai; Prommanee, Duangprom; Monnapha, Wannasri; Sirintip, Khankham; Chayanis, Kositamongkol; Nathorn, Chaiyakunapruk; Pochamana, PhisalprapaMedicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2021, 100(5): e24557.
- Quantitative assessment of fibrosis-4 score and adverse clinical outcomes in patients with COVID-19Tang, Kefu; Wang, Lu; Shen, Lu; He, Lin*; Wu, Xi*Science China Life Sciences, 2022, 65(12): 2560-2563.
会议论文
Fibrosis-4 index predicts adverse cardiovascular outcomes among patients comorbid with MAFLD and coronary heart disease
7阅读
